Finding common ground on how “best” to treat localized prostate cancer, and what to tell the patients

One of the hardest issues for newly diagnosed prostate cancer patients to deal with has long been the differences in opinion between physicians about appropriate first-line treatment (and the relevant information they are offered) — most especially for patients with localized disease. … READ MORE …

ICER/Families USA “Proven Best Choices” for treatment of low-risk prostate cancer

According to a report from Kaiser Health News, the consumer organization Families USA is collaborating with the Institute for Clinical and Economic Review (ICER) to provide a series of “Proven Best Choices” guides for patients about screening and treatments for selected disorders. … READ MORE …

Can a new logistical approach radically change surgical options for patients?

One of the things we have been asked multiple times over the years is “What does it cost to have” a radical prostatectomy, or a penile implant, or some other prostate cancer-related procedure. Usually, we have had some idea, but it can be near to impossible to get precise, total costs for such procedures — even from your local hospital. … READ MORE …

“Please take notes if you want to, but I’m going to give you an audio-recording of this meeting to take home”

For the majority of newly diagnosed prostate cancer patients, the first meeting with their physician after diagnosis presents them with more information than they are able to assimilate easily … and many patients don’t have the necessary scientific or medical background to understand everything they are being told — even if they hear it all. … READ MORE …

Education about possible management options for prostate cancer BEFORE biopsy

Data from a small, recently published pilot study offers some interesting information about the impact of providing good quality educational information to patients about options for the management of prostate cancer before they were ever given their biopsy (i.e., before their diagnosis of cancer is a certainty). … READ MORE …

Age, communication, and access to appropriate prostate cancer services/options

Newly reported data from the German HAROW study suggests that older men diagnosed with prostate cancer are less informed that younger men about access to things like patient support groups, post-treatment rehabilitation services, and second medical opinions. … READ MORE …

Decision aids and patient choice of therapy: a randomized, controlled, clinical trial

A new paper in BJU International reports data about the development of an appropriate decision aid and the results of a randomized, controlled, clinical trial designed to investigate the effects of use of that decision aid (as opposed to “usual care”) on patients’ selection of radiation therapy as opposed to radical prostatectomy for localized disease. … READ MORE …